Race Oncology Limited (ASX: RAC)
Australia
· Delayed Price · Currency is AUD 1.430
+0.070 (5.15%)
Nov 21, 2024, 4:10 PM AEST
Race Oncology Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Other Revenue | 4 | 4 | 3.13 | 0.71 | 0.39 | 0.16 | Upgrade
|
| Revenue | 4 | 4 | 3.13 | 0.71 | 0.39 | 0.16 | Upgrade
|
| Revenue Growth (YoY) | 27.73% | 27.73% | 342.83% | 82.71% | 143.07% | -30.25% | Upgrade
|
| Cost of Revenue | 2.61 | 2.61 | 2.03 | 0.99 | 0.62 | 0.44 | Upgrade
|
| Gross Profit | 1.39 | 1.39 | 1.11 | -0.28 | -0.23 | -0.28 | Upgrade
|
| Selling, General & Admin | 3.79 | 3.79 | 3.04 | 4.33 | 3.34 | 1.95 | Upgrade
|
| Research & Development | 10.98 | 10.98 | 7.6 | 5.83 | 2.2 | 1.28 | Upgrade
|
| Other Operating Expenses | 0.82 | 0.82 | 0.66 | 0.48 | 0.31 | 0.14 | Upgrade
|
| Operating Expenses | 15.87 | 15.87 | 11.58 | 10.92 | 6.13 | 3.65 | Upgrade
|
| Operating Income | -14.48 | -14.48 | -10.48 | -11.2 | -6.36 | -3.93 | Upgrade
|
| Interest & Investment Income | 0.83 | 0.83 | 0.59 | 0.05 | 0.02 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | -0.17 | -0.04 | -0.05 | -0.04 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -13.82 | -13.82 | -9.92 | -11.2 | -6.38 | -3.93 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.04 | 0.08 | Upgrade
|
| Pretax Income | -13.82 | -13.82 | -9.92 | -11.2 | -6.34 | -3.85 | Upgrade
|
| Net Income | -13.82 | -13.82 | -9.92 | -11.2 | -6.34 | -3.85 | Upgrade
|
| Net Income to Common | -13.82 | -13.82 | -9.92 | -11.2 | -6.34 | -3.85 | Upgrade
|
| Shares Outstanding (Basic) | 165 | 165 | 161 | 153 | 131 | 107 | Upgrade
|
| Shares Outstanding (Diluted) | 165 | 165 | 161 | 153 | 131 | 107 | Upgrade
|
| Shares Change (YoY) | 2.35% | 2.35% | 4.83% | 17.06% | 22.86% | 33.50% | Upgrade
|
| EPS (Basic) | -0.08 | -0.08 | -0.06 | -0.07 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.08 | -0.06 | -0.07 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -9.55 | -9.55 | -10.65 | -6.26 | -4.7 | -2.46 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.06 | -0.07 | -0.04 | -0.04 | -0.02 | Upgrade
|
| Gross Margin | 34.72% | 34.72% | 35.35% | -39.91% | -60.07% | -178.09% | Upgrade
|
| Operating Margin | -361.80% | -361.80% | -334.22% | -1582.76% | -1641.48% | -2466.26% | Upgrade
|
| Profit Margin | -345.18% | -345.18% | -316.60% | -1582.63% | -1636.70% | -2413.22% | Upgrade
|
| Free Cash Flow Margin | -238.43% | -238.43% | -339.83% | -884.12% | -1212.64% | -1545.50% | Upgrade
|
| EBITDA | -14.2 | -14.2 | -10.19 | -10.92 | -6.08 | -3.65 | Upgrade
|
| D&A For EBITDA | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| EBIT | -14.48 | -14.48 | -10.48 | -11.2 | -6.36 | -3.93 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.